Tag: first-mover advantage

• DARREN LLOYD
• 2

The first generic manufacturer to launch after a brand drug’s patent expires captures up to 90% of the market and often retains 30-40% long-term due to pharmacy stocking habits and patient loyalty. This advantage is protected by the Hatch-Waxman Act’s 180-day exclusivity rule.